Fuso Pharmaceutical Industries,Ltd. 4538Short Interest
No institution currently reports a short position of 0.5% or more in Fuso Pharmaceutical Industries,Ltd. (4538). The last disclosure was on 2026-10-29 (Barclays Capital Securities Ltd, 0.00%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
41 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2023-12-18 |
|---|---|
| Latest disclosure | 2026-10-29 (Barclays Capital Securities Ltd, 0.00%) |
| Reporting institutions | 3 firms (41 reports) |
| Peak estimated short interest | 1.13% (2025-09-17, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- Nomura International plc
- MERRILL LYNCH INTERNATIONAL
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2023-12-22 | MERRILL LYNCH INTERNATIONAL | Position 46,862 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2024-01-16 | Nomura International plc | Position 41,300 shares | Ratio 0.43% | ▼0.09% | Below 0.5% |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 102 shares | Ratio 0.00% | ▼0.69% | Closed |
Disclosure History 41 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-29 | Barclays Capital Securities Ltd | Position 102 shares | Ratio 0.00% | ▼0.69% | Closed |
| 2026-10-28 | Barclays Capital Securities Ltd | Position 65,402 shares | Ratio 0.69% | ▼0.01% | — |
| 2026-10-23 | Barclays Capital Securities Ltd | Position 66,502 shares | Ratio 0.70% | ▲0.08% | — |
| 2026-10-20 | Barclays Capital Securities Ltd | Position 59,402 shares | Ratio 0.62% | ▲0.03% | — |
| 2026-10-09 | Barclays Capital Securities Ltd | Position 56,602 shares | Ratio 0.59% | ▼0.01% | — |
| 2026-10-08 | Barclays Capital Securities Ltd | Position 57,302 shares | Ratio 0.60% | ▲0.01% | — |
| 2026-10-07 | Barclays Capital Securities Ltd | Position 55,802 shares | Ratio 0.59% | ▼0.10% | — |
| 2026-10-05 | Barclays Capital Securities Ltd | Position 66,132 shares | Ratio 0.69% | ▲0.40% | — |
| 2026-08-28 | Barclays Capital Securities Ltd | Position 45,100 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2026-08-19 | Barclays Capital Securities Ltd | Position 56,670 shares | Ratio 0.59% | ▼0.09% | — |
| 2026-08-17 | Barclays Capital Securities Ltd | Position 64,800 shares | Ratio 0.68% | ▼0.05% | — |
| 2026-08-14 | Barclays Capital Securities Ltd | Position 69,800 shares | Ratio 0.73% | ▼0.15% | — |
| 2026-07-29 | Barclays Capital Securities Ltd | Position 83,402 shares | Ratio 0.88% | ▼0.03% | — |
| 2026-07-16 | Barclays Capital Securities Ltd | Position 86,802 shares | Ratio 0.91% | ▲0.02% | — |
| 2026-06-29 | Barclays Capital Securities Ltd | Position 75,356 shares | Ratio 0.79% | ▼0.10% | — |
| 2026-06-12 | Barclays Capital Securities Ltd | Position 84,756 shares | Ratio 0.89% | ▼0.05% | — |
| 2026-06-02 | Barclays Capital Securities Ltd | Position 89,156 shares | Ratio 0.94% | ▲0.13% | — |
| 2026-05-25 | Barclays Capital Securities Ltd | Position 77,056 shares | Ratio 0.81% | ▲0.07% | — |
| 2026-05-13 | Barclays Capital Securities Ltd | Position 69,957 shares | Ratio 0.74% | ▲0.23% | — |
| 2026-05-11 | Barclays Capital Securities Ltd | Position 48,257 shares | Ratio 0.51% | ▼0.10% | — |
| 2026-05-08 | Barclays Capital Securities Ltd | Position 58,256 shares | Ratio 0.61% | ▲0.09% | — |
| 2026-04-20 | Barclays Capital Securities Ltd | Position 49,455 shares | Ratio 0.52% | ▲0.08% | — |
| 2026-04-15 | Barclays Capital Securities Ltd | Position 41,756 shares | Ratio 0.44% | ▼0.06% | Below 0.5% |
| 2026-04-14 | Barclays Capital Securities Ltd | Position 48,056 shares | Ratio 0.50% | ▲0.08% | — |
| 2026-02-16 | Barclays Capital Securities Ltd | Position 46,841 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-02-12 | Barclays Capital Securities Ltd | Position 48,541 shares | Ratio 0.51% | ▲0.07% | — |
| 2025-09-19 | Barclays Capital Securities Ltd | Position 0 shares | Ratio 0.00% | ▼1.13% | Closed |
| 2025-09-17 | Barclays Capital Securities Ltd | Position 107,441 shares | Ratio 1.13% | ▲0.10% | — |
| 2025-09-11 | Barclays Capital Securities Ltd | Position 98,041 shares | Ratio 1.03% | ▲0.13% | — |
| 2025-09-08 | Barclays Capital Securities Ltd | Position 85,341 shares | Ratio 0.90% | ▲0.08% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |